Search research articles
Contact Us
Filters
Showing results (181-190 of 272) with videos related to
Page
of 28
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
April 13, 2023
Long-Term Outcomes in IgA Nephropathy
David Pitcher, Fiona Braddon, Bruce Hendry, et al.
Kidney International
|
March 26, 2017
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
Hernán Trimarchi, Jonathan Barratt, Daniel C Cattran, et al.
Kidney Medicine
|
March 5, 2026
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies
Mahtab Mashayekhi, Jonathan E Zuckerman, Jonathan Barratt, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 6, 2023
Targeting APRIL in the Treatment of IgA Nephropathy
Chee Kay Cheung, Jonathan Barratt, Kevin Carroll, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
September 11, 2019
Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled Trial
Hari Dukka, Philip A Kalra, Martin Wilkie, et al.
Kidney International Reports
|
December 22, 2025
DMX-200 in Patients With Primary Focal Segmental Glomerulosclerosis: Results of the Phase 2 ACTION2 Trial
Hiddo J L Heerspink, Alessia Fornoni, Lesley A Inker, et al.
Kidney International Reports
|
December 19, 2024
Scoping Review of Economic Analyses of Rare Kidney Diseases
Blake Angell, Siyuan Wang, Thomas Gadsden, et al.
The New England Journal of Medicine
|
October 26, 2024
Atrasentan in Patients with IgA Nephropathy
Hiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International
|
June 28, 2025
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy
Jürgen Floege, Richard Lafayette, Jonathan Barratt, et al.
The New England Journal of Medicine
|
November 2, 2023
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Mohit Mathur, Jonathan Barratt, Bobby Chacko, et al.
Page
of 28
Search research articles
Search
Showing results (181-190 of 272) with videos related to
Sort By:
Page
of 28
Clinical Journal of the American Society of Nephrology : CJASN
|
April 13, 2023
Long-Term Outcomes in IgA Nephropathy
David Pitcher, Fiona Braddon, Bruce Hendry, et al.
Kidney International
|
March 26, 2017
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
Hernán Trimarchi, Jonathan Barratt, Daniel C Cattran, et al.
Kidney Medicine
|
March 5, 2026
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies
Mahtab Mashayekhi, Jonathan E Zuckerman, Jonathan Barratt, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 6, 2023
Targeting APRIL in the Treatment of IgA Nephropathy
Chee Kay Cheung, Jonathan Barratt, Kevin Carroll, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
September 11, 2019
Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled Trial
Hari Dukka, Philip A Kalra, Martin Wilkie, et al.
Kidney International Reports
|
December 22, 2025
DMX-200 in Patients With Primary Focal Segmental Glomerulosclerosis: Results of the Phase 2 ACTION2 Trial
Hiddo J L Heerspink, Alessia Fornoni, Lesley A Inker, et al.
Kidney International Reports
|
December 19, 2024
Scoping Review of Economic Analyses of Rare Kidney Diseases
Blake Angell, Siyuan Wang, Thomas Gadsden, et al.
The New England Journal of Medicine
|
October 26, 2024
Atrasentan in Patients with IgA Nephropathy
Hiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International
|
June 28, 2025
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy
Jürgen Floege, Richard Lafayette, Jonathan Barratt, et al.
The New England Journal of Medicine
|
November 2, 2023
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Mohit Mathur, Jonathan Barratt, Bobby Chacko, et al.
Page
of 28